in

Moderna would seek limited emergency use of COVID-19 vaccine based on early data

If Moderna Inc’s COVID-19 vaccine proves to be at least 70 per cent effective, the company plans to seek emergency authorization for its use in high-risk groups, the company’s chief executive told Reuters.

Reference